Learn how KMA and LMA represent a breakthrough in treatment approaches for multiple myeloma and related disorders.

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

New research suggests the skin does much more than detect damage or keep pathogens out. By tracing how skin cells respond to ...

A patient developed granulomatosis with polyangiitis (GPA), a type of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), following a long-standing history of systemic lupus ...

Researchers developed a micro-volume assay that quantifies T-cell responses and antibodies from fingertip blood, offering a ...

The use of the nucleic acid platform for antigen delivery has expanded rapidly in the past decade, highlighted by the development and deployment of several nucleic acid vaccines for SARS-CoV-2 and the ...

Talquetamab delivers high response rates in refractory myeloma; learn how to prevent skin, nail and oral side effects to stay on therapy. As the therapeutic arsenal for relapsed/refractory multiple ...

After a strong start to the year, the value of biotech financings has tailed off a little, but March has seen a clutch of $50 ...

To further expand its global presence and ensure widespread vaccine availability, SII has established Serum Life Sciences Ltd, a subsidiary in the UK. Through relentless pursuit of innovation, SII ...

An AI model that screens ionizable lipids by 3D conformation identified a candidate 14.8 times more efficient than current ...

The boss of Yorkshire-based lateral flow test developer Abingdon Health has said the company is still benefiting after the pandemic turned a once rarely discussed product into a household name.